Scan to download
BTC $59,533.25 -0.54%
ETH $1,592.65 +1.00%
BNB $552.52 -0.08%
XRP $1.04 +0.23%
SOL $74.04 +2.62%
TRX $0.3192 -1.07%
DOGE $0.0724 -0.74%
ADA $0.1453 +0.46%
BCH $199.26 +1.61%
LINK $7.30 +0.13%
HYPE $65.45 +4.52%
AAVE $90.83 -1.09%
SUI $0.6966 +0.84%
XLM $0.1839 +5.92%
ZEC $399.23 +4.43%
BTC $59,533.25 -0.54%
ETH $1,592.65 +1.00%
BNB $552.52 -0.08%
XRP $1.04 +0.23%
SOL $74.04 +2.62%
TRX $0.3192 -1.07%
DOGE $0.0724 -0.74%
ADA $0.1453 +0.46%
BCH $199.26 +1.61%
LINK $7.30 +0.13%
HYPE $65.45 +4.52%
AAVE $90.83 -1.09%
SUI $0.6966 +0.84%
XLM $0.1839 +5.92%
ZEC $399.23 +4.43%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01
Collection

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.